Chesapeake Asset Management’s Clover Health Investments CLOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$12.6K Hold
2,400
0.01% 222
2026
Q1
$4.22K Hold
2,400
﹤0.01% 285
2025
Q4
$5.64K Hold
2,400
﹤0.01% 293
2025
Q3
$7.34K Hold
2,400
0.01% 248
2025
Q2
$6.7K Hold
2,400
0.01% 239
2025
Q1
$8.62K Hold
2,400
0.01% 228
2024
Q4
$7.56K Hold
2,400
0.01% 231
2024
Q3
$6.77K Hold
2,400
0.01% 234
2024
Q2
$2.95K Hold
2,400
﹤0.01% 272
2024
Q1
$1.91K Hold
2,400
﹤0.01% 278
2023
Q4
$2.29K Hold
2,400
﹤0.01% 342
2023
Q3
$2.59K Hold
2,400
﹤0.01% 359
2023
Q2
$2.15K Hold
2,400
﹤0.01% 356
2023
Q1
$2.03K Buy
+2,400
New +$2.63K ﹤0.01% 356

Other funds holding CLOV

Chesapeake Asset Management's CLOV Position: Q2 2026 in Review

Chesapeake Asset Management held its Clover Health Investments (CLOV) position steady in Q2 2026 at 2,400 shares worth $12.6K. The position accounts for 0.01% of the portfolio, ranked #222.

Chesapeake Asset Management first reported a position in CLOV in Q1 2023 and has held it in 14 quarters since. 227 funds tracked by Wall St. Rank hold CLOV as of Q2 2026.

  • Chesapeake Asset Management held 2,400 shares of Clover Health Investments worth $12.6K as of Q2 2026.
  • Chesapeake Asset Management left its Clover Health Investments share count unchanged in Q2 2026.
  • Clover Health Investments made up 0.01% of Chesapeake Asset Management's portfolio in Q2 2026, its #222 holding.
  • Chesapeake Asset Management first reported a position in Clover Health Investments in Q1 2023 and has held it in 14 quarters since.
  • 227 funds tracked by Wall St. Rank held Clover Health Investments as of Q2 2026.

Based on Chesapeake Asset Management's 13F filing for Q2 2026, filed 4 Aug 2026.